Mersana Therapeutics, Inc. (MRSN) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 175.23M |
| Enterprise Value | 96.08M |
| P/E Ratio | -2.07 |
| PEG Ratio | -0.28 |
| Price/Sales Ratio | 4.38 |
| Price/Book Ratio | -2.44 |
| Enterprise/Revenue | 2.75 |
| Enterprise/EBITDA | -1.38 |
Fiscal Year
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | September 30, 2025 |
Profitability
| Profit Margin | -2.11 |
| Operating Margin | -2.03 |
AD
Management Effectiveness
| Return On Assets | -1.12 |
| Return On Equity | 1.83 |
Income Statement
| Revenue | 40.5M |
| Revenue/Share | 6.65 |
| Gross Profit | 40.5M |
| EBITDA | -63.27M |
| Net Income | -69.19M |
| Diluted EPS | -14.12 |
Balance Sheet
| Total Cash | 56.39M |
| Total Cash/Share | 11.31 |
| Total Debt | 2.29M |
| Total Debt/Equity | -0.04 |
| Current Ratio | 1.39 |
| Book Value Per Share | -11.94 |
Price History
| 52-Week Change | 62.01 |
| 52-Week High | 30.39 |
| 52-Week Low | 5.21 |
| Moving Average 50 Days | 22.88 |
| Moving Average 200 Days | 11.99 |
Statistics
| Average Volume | 135,968 |
| Shares Outstanding | 5M |
| % Held by Institutions | 45.01 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
| Last Split Date | July 28, 2025 |
AD
